5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR).
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002855:Chromatography, Thin Layer; D003841:Deoxycytidine / Q000627:therapeutic use; D003857:Deoxyuridine / Q000627:therapeutic use; D003956:Dialysis; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005467:Floxuridine / Q000097:blood / Q000627:therapeutic use*; D005472:Fluorouracil / Q000097:blood / Q000627:therapeutic use*; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D005467:Floxuridine; D003841:Deoxycytidine; D005472:Fluorouracil; D003857:Deoxyuridine